title: Drug based approaches for targeting tumor vasculature: development of combretastatin A4 phosphate.
authors.affiliation: Oxigene Inc, Watertown, MA 02472, USA. dchaplin@oxigene.com
authors.forename: David J
authors.initials: DJ
authors.lastname: Chaplin
mesh_terms: D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology / Q000627:therapeutic use; D016503:Drug Delivery Systems; D006801:Humans; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy; D013267:Stilbenes / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D050257:Tubulin Modulators
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D013267:Stilbenes; D050257:Tubulin Modulators; C058728:fosbretabulin